Decoy Therapeutics Inc（DCOY）美股招股说明书 S-1（2026-06-15首版）（英文版）（45页）.pdf

1、S-1 1 dcoy-20260612.htm S-1 As filed with the Securities and Exchange Commission on June 12,2026Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933DECOY THERAPEUTICS INC.(Exact name of registrant as spec

2、ified in its charter)Delaware(State or other jurisdiction of incorporation or organization)2834(Primary Standard Industrial Classification Code Number)46-5087339(I.R.S.Employer Identification Number)2450 Holcombe Blvd.,Suite XHouston,TX 77021(713)913-5608(Address,including zip code,and telephone num

3、ber,including area code,of registrants principal executive offices)Frederick E.PierceChief Executive OfficerDecoy Therapeutics Inc.2450 Holcombe Blvd.,Suite XHouston,TX 77021(713)913-5608(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:Jeffrey

4、H.Kuras,Esq.Honigman LLP660 Woodward Avenue,2290 First National BuildingDetroit,MI 48226(313)465-7000Approximate date of commencement of proposed sale to the public:From time to time after the effective date of this registration statement,as determined by the selling stockholder.If any of the securi

5、ties being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check the follow

6、ing box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box and list the Securities Act registration st